FR3090691B1 - Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci - Google Patents

Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci Download PDF

Info

Publication number
FR3090691B1
FR3090691B1 FR1873492A FR1873492A FR3090691B1 FR 3090691 B1 FR3090691 B1 FR 3090691B1 FR 1873492 A FR1873492 A FR 1873492A FR 1873492 A FR1873492 A FR 1873492A FR 3090691 B1 FR3090691 B1 FR 3090691B1
Authority
FR
France
Prior art keywords
bacteria
genetically modified
preparation
clostridium bacteria
modified clostridium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1873492A
Other languages
English (en)
Other versions
FR3090691A1 (fr
Inventor
Rémi Hocq
Gwladys Chartier
François WASELS
Ferreira Nicolas Lopes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IFP Energies Nouvelles IFPEN
Original Assignee
IFP Energies Nouvelles IFPEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1873492A priority Critical patent/FR3090691B1/fr
Application filed by IFP Energies Nouvelles IFPEN filed Critical IFP Energies Nouvelles IFPEN
Priority to CA3123468A priority patent/CA3123468A1/fr
Priority to KR1020217022031A priority patent/KR20210118826A/ko
Priority to CN201980088931.2A priority patent/CN113614229A/zh
Priority to JP2021536334A priority patent/JP2022516025A/ja
Priority to EP19848893.4A priority patent/EP3898970A1/fr
Priority to PCT/FR2019/053227 priority patent/WO2020128379A1/fr
Priority to US17/414,337 priority patent/US20230109758A1/en
Priority to BR112021011983-3A priority patent/BR112021011983A2/pt
Publication of FR3090691A1 publication Critical patent/FR3090691A1/fr
Application granted granted Critical
Publication of FR3090691B1 publication Critical patent/FR3090691B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/06—Ethanol, i.e. non-beverage
    • C12P7/065—Ethanol, i.e. non-beverage with microorganisms other than yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • C12P7/16—Butanols
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y203/00—Acyltransferases (2.3)
    • C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12Y203/01028—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

BACTERIES CLOSTRIDIUM GENETIQUEMENT MODIFIEES, PREPARATION ET UTILISATIONS DE CELLES-CI La présente invention concerne la modification génétique de bactéries du genre Clostridium, typiquement de bactéries solvantogènes du genre Clostridium, en particulier de bactéries possédant à l’état sauvage un gène codant une amphénicol-O-acetyltransférase. Elle concerne ainsi des méthodes, outils et kits permettant une telle modification génétique, en particulier l’élimination ou la modification d’une séquence codant ou contrôlant la transcription d’une amphénicol-O-acetyltransférase, les bactéries génétiquement modifiées obtenues et leurs utilisations, en particulier pour produire un solvant, de préférence à l’échelle industrielle.
FR1873492A 2018-12-20 2018-12-20 Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci Active FR3090691B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR1873492A FR3090691B1 (fr) 2018-12-20 2018-12-20 Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci
KR1020217022031A KR20210118826A (ko) 2018-12-20 2019-12-20 유전자 변형된 클로스트리디움 박테리아, 그의 제조 및 용도
CN201980088931.2A CN113614229A (zh) 2018-12-20 2019-12-20 遗传修饰的梭菌属细菌、其制备和用途
JP2021536334A JP2022516025A (ja) 2018-12-20 2019-12-20 遺伝子的に改変されたｃｌｏｓｔｒｉｄｉｕｍ細菌の、調製およびその使用。
CA3123468A CA3123468A1 (fr) 2018-12-20 2019-12-20 Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci
EP19848893.4A EP3898970A1 (fr) 2018-12-20 2019-12-20 Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci
PCT/FR2019/053227 WO2020128379A1 (fr) 2018-12-20 2019-12-20 Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci
US17/414,337 US20230109758A1 (en) 2018-12-20 2019-12-20 Genetically modified clostridium bacteria, preparation and uses of same
BR112021011983-3A BR112021011983A2 (pt) 2018-12-20 2019-12-20 Bactérias clostridium geneticamente modificadas, preparação e utilização das mesmas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1873492A FR3090691B1 (fr) 2018-12-20 2018-12-20 Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci

Publications (2)

Publication Number Publication Date
FR3090691A1 FR3090691A1 (fr) 2020-06-26
FR3090691B1 true FR3090691B1 (fr) 2023-06-09

Family

ID=67185129

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1873492A Active FR3090691B1 (fr) 2018-12-20 2018-12-20 Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci

Country Status (9)

Country Link
US (1) US20230109758A1 (fr)
EP (1) EP3898970A1 (fr)
JP (1) JP2022516025A (fr)
KR (1) KR20210118826A (fr)
CN (1) CN113614229A (fr)
BR (1) BR112021011983A2 (fr)
CA (1) CA3123468A1 (fr)
FR (1) FR3090691B1 (fr)
WO (1) WO2020128379A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3096373A1 (fr) * 2019-05-24 2020-11-27 IFP Energies Nouvelles Outil genetique optimisé pour modifier les bacteries

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101903530A (zh) * 2007-10-12 2010-12-01 加利福尼亚大学董事会 被改造以产生异丙醇的微生物
WO2009131040A1 (fr) * 2008-04-25 2009-10-29 財団法人地球環境産業技術研究機構 Bactéries corynéformes génétiquement modifiées capables de produire de l’isopropanol
FR2981089B1 (fr) * 2011-10-11 2016-05-20 Ifp Energies Now Production d'isopropanol par des souches recombinantes ameliorees
WO2013109982A1 (fr) * 2012-01-19 2013-07-25 Butrolix Llc Procédés de production améliorée de butanol par clostridia
FR3037076B1 (fr) * 2015-06-04 2018-11-09 IFP Energies Nouvelles Souches mutantes du genre clostridium beijerinckii
FR3042506B1 (fr) * 2015-10-16 2018-11-30 IFP Energies Nouvelles Outil genetique de transformation de bacteries clostridium

Also Published As

Publication number Publication date
CN113614229A (zh) 2021-11-05
JP2022516025A (ja) 2022-02-24
CA3123468A1 (fr) 2020-06-25
FR3090691A1 (fr) 2020-06-26
KR20210118826A (ko) 2021-10-01
EP3898970A1 (fr) 2021-10-27
BR112021011983A2 (pt) 2021-09-14
US20230109758A1 (en) 2023-04-13
WO2020128379A1 (fr) 2020-06-25

Similar Documents

Publication Publication Date Title
WO2015119941A3 (fr) Fractionnement du génome
MA54578A1 (fr) Tolérance des plantes de solanum lycopersicum au tobamovirus dit virus du fruit rugueux brun de tomate (tbrfv)
AR113458A1 (es) Método para regular la expresión génica
EA202090540A1 (ru) Ген, придающий устойчивость к патогенному грибу
WO2019094725A3 (fr) Modification génétique de gène de protéine contenant sh2 inductible par la cytokine (cish)
BR112021017801A2 (pt) Anticorpos biespecíficos anti-vbeta17/anti-cd123
MX2021008592A (es) Composiciones de trem y usos de las mismas.
CL2017003140A1 (es) Composicion anti-incrustante y proceso para su producción
FR3094181B1 (fr) Composition proteique de feverole
UY38992A (es) Mutación de los factores de transcripción de la familia de factores reguladores de crecimiento para mejorar el crecimiento de plantas
FR3090691B1 (fr) Bacteries clostridium genetiquement modifiees, preparation et utilisations de celles-ci
EP4269610A3 (fr) Sonde et procédé de détection d'un produit de transcription résultant d'un gène de fusion et/ou d'un saut d'exon
WO2018053119A3 (fr) Méthodes et applications d'amplification de séquences de répertoires immunologiques
BR112022012731A2 (pt) Anticorpo anti-ox40 e uso do mesmo
EP3752622A4 (fr) Procédés et compositions pour augmenter le rendement récoltable par l'édition de gènes de ga20 oxydase pour générer des plantes de petite taille
MX2021015301A (es) Métodos de cultivo celular y composiciones para la producción de anticuerpos.
EP4085933A3 (fr) Compositions et procédés pour la production de composés
EP4235680A3 (fr) Procédé et appareil destinés à une représentation compacte de données bioinformatiques
AU2017248848A1 (en) Enhanced gene delivery methods
MX2020005939A (es) Mejoramiento de la productividad de lipidos de algas a traves de la modificacion genetica de una proteina que contiene un dominio tpr.
MX2020003979A (es) Metodo de procesamiento para biopolimeros utilizando combinaciones de solventes.
AR110615A1 (es) Gen alkb mutante
WO2018074865A3 (fr) Composition et procédé pour la prédiction de pronostic du cancer du sein
NZ751447A (en) Resistance gene to rhizomania
PH12019502417A1 (en) Method of determining expression level ot t315i variant of abl1

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200626

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6